(R)-(-)-Carvone

IMPURITIES

Product Details

CAT No.# CS-T-68907
Category Impurities
CAS 6485-40-1
Molecular Weight 150.22
Molecular Formula C₁₀H₁₄O
Stock Status: In-Stock
Melting Point: N/A
Solubility: Chloroform, Methanol
Appearance: Clear Colorless Oil
Synonyms: (5R)-2-Methyl-5-(1-methylethenyl)-2-cyclohexen-1-one; (R)-(-)-p-Mentha-6,8-dien-2-one; (-)-(5R)-Carvone; (-)-(R)-Carvone; (-)-p-Mentha-6,8-dien-2-one; (4R)-(-)-Carvone; (R)-Carvone; (R)-Carvone; L-(-)-Carvone; L-Carvone; R-(-)-Carvone; l-1-Methyl-4-isopropenyl-6-cyclohexen-2-one; l-Carvone;
Application Notes: (R)-(-)-Carvone, is an antinociceptive monoterpene found as the main active constituent of essential oils obtained from plants of the genus Mentha. It is a novel agonist of TRPV1 channels. It can also be used as a chiral starting material.
Storage: Amber Vial, For long term store at -20°C, Under inert atmosphere
Shipping: Free Shipping for worldwide on order above 2000 USD , Extra charges for Dry ice shipment 80$*
COA / MSDS:    View COA    MSDS
The balance used are calibrated with weights traceable to National Standards NIST for accuracy
PEOPLE ALSO SEARCHED FOR: 1. propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylate
2. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
3. Benidipine D7
4. Lauroside D
5. Triazolam 13C D3
6. Icatibant impurity 1
7. BISPHENOL AF (RING-13C12)
8. 0.1% TFA in Water ULC-MS
9. Metamizole EP Impurity C HCl
10. Silodosin Metabolite D4
11. Brivaracetam Carboxylic acid metabolite [UCB 42145]
12. Terbuthylazine D5
13. tibolone (848)
14. (Z)-Dimethylvinphos
15. Silodosin Metabolite
16. 2-Phenoxymethanesulfonanilide
17. Nimesulide EP Impurity A
18. Acetone HPLC
19. Nandrolone Decanoate EP impurity F
20. N-(4-Bromophenyl)-3-methyl-N-(m-tolyl)aniline


Smileys:
O=C1C(C)=CC[C@@H](C(C)=C)C1



This page contains information about (R)-(-)-Carvone Cas 6485-40-1 and its Impurities.
"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."